Data, quality and trial management top the list of ways the industry is using artificial intelligence (AI) and machine learning (ML), according to a new survey of the technologies’ impact on clinical trials. Read More
Virtual training for study startup is not only saving time and money, it’s providing more in-depth learning and improved communications between sites and sponsors. Read More
Following through on its statement that it doesn’t expect COVID-19 vaccine sponsors to conduct separate large-scale trials to address variants of the virus, the FDA has outlined additional information the agency needs to amend current Emergency Use Authorizations (EUA). Read More
Changes in COVID-19-related research (CIR) submissions surged suddenly in Spring 2020, according to data from the WCG Knowledge Base, as sponsors and researchers quickly adjusted research plans with shifts to virtual study visits, remote measurement of study endpoints and modifications to informed consent processes. Read More
The pandemic is continuing to disrupt clinical trials in 2021, but the impact varies by therapeutic area, according to data analysis firm GlobalData. Read More
ICON says it plans to acquire rival PRA Health Sciences in a $12 billion deal that would create one of the world’s largest CROs with the potential for a huge expansion into decentralized and hybrid clinical trials. Read More
The rate of CRA turnover at U.S. CROs hit a new six-year low in November, declining to more than 21 percent, according to a newly released poll of 15 CROs. Read More
